Literature DB >> 22941567

The impact of rural residency on the expression and outcome of systemic lupus erythematosus: data from a multiethnic Latin American cohort.

G J Pons-Estel1, V Saurit, G S Alarcón, L Hachuel, G Boggio, D Wojdyla, J L Alfaro-Lozano, I García de la Torre, L Massardo, M H Esteva-Spinetti, M Guibert-Toledano, L A Ramirez Gómez, L T Lavras Costallat, M J Sauza Del Pozo, L H Silveira, F Cavalcanti, B A Pons-Estel.   

Abstract

OBJECTIVE: The objective of this paper is to examine the role of place of residency in the expression and outcomes of systemic lupus erythematosus (SLE) in a multi-ethnic Latin American cohort. PATIENTS AND METHODS: SLE patients (< two years of diagnosis) from 34 centers constitute this cohort. Residency was dichotomized into rural and urban, cut-off: 10,000 inhabitants. Socio-demographic, clinical/laboratory and mortality rates were compared between them using descriptive tests. The influence of place of residency on disease activity at diagnosis and renal disease was examined by multivariable regression analyses.
RESULTS: Of 1426 patients, 122 (8.6%) were rural residents. Their median ages (onset, diagnosis) were 23.5 and 25.5 years; 85 (69.7%) patients were Mestizos, 28 (22.9%) Caucasians and 9 (7.4%) were African-Latin Americans. Rural residents were more frequently younger at diagnosis, Mestizo and uninsured; they also had fewer years of education and lower socioeconomic status, exhibited hypertension and renal disease more frequently, and had higher levels of disease activity at diagnosis; they used methotrexate, cyclophosphamide pulses and hemodialysis more frequently than urban patients. Disease activity over time, renal damage, overall damage and the proportion of deceased patients were comparable in rural and urban patients. In multivariable analyses, rural residency was associated with high levels of disease activity at diagnosis (OR 1.65, 95% CI 1.06-2.57) and renal disease occurrence (OR 1.77, 95% CI 1.00-3.11).
CONCLUSIONS: Rural residency associates with Mestizo ethnicity, lower socioeconomic status and renal disease occurrence. It also plays a role in disease activity at diagnosis and kidney involvement but not on the other end-points examined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22941567      PMCID: PMC3758687          DOI: 10.1177/0961203312458465

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  29 in total

1.  Hospital experience and expected mortality in patients with systemic lupus erythematosus: a hospital level analysis.

Authors:  M M Ward
Journal:  J Rheumatol       Date:  2000-09       Impact factor: 4.666

2.  Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women.

Authors:  W J Fessel
Journal:  Arch Intern Med       Date:  1974-12

3.  Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965.

Authors:  M Siegel; H L Holley; S L Lee
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

Review 4.  Epidemiology of systemic lupus erythematosus.

Authors:  S Manzi
Journal:  Am J Manag Care       Date:  2001-10       Impact factor: 2.229

Review 5.  Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?

Authors:  Karen H Costenbader; Steffen Gay; Marta E Alarcón-Riquelme; Luca Iaccarino; Andrea Doria
Journal:  Autoimmun Rev       Date:  2011-10-25       Impact factor: 9.754

6.  Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.

Authors:  G S Alarcón; G McGwin; A A Bartolucci; J Roseman; J Lisse; B J Fessler; H M Bastian; A W Friedman; J D Reveille
Journal:  Arthritis Rheum       Date:  2001-12

7.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979.

Authors:  C J Michet; C H McKenna; L R Elveback; R A Kaslow; L T Kurland
Journal:  Mayo Clin Proc       Date:  1985-02       Impact factor: 7.616

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics".

Authors:  Bernardo A Pons-Estel; Luis J Catoggio; Mario H Cardiel; Enrique R Soriano; Silvana Gentiletti; Antonio R Villa; Isaac Abadi; Francisco Caeiro; Alejandro Alvarellos; Donato Alarcón-Segovia
Journal:  Medicine (Baltimore)       Date:  2004-01       Impact factor: 1.889

10.  Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis.

Authors:  Karen H Costenbader; Daniel J Kim; Jehanna Peerzada; Shahin Lockman; Dolores Nobles-Knight; Michelle Petri; Elizabeth W Karlson
Journal:  Arthritis Rheum       Date:  2004-03
View more
  6 in total

1.  Comparison of the Prevalence of Antinuclear Antibody and Subserology in Urban and Rural Settings.

Authors:  Adrian Yong-Sing Lee; Leigh Murfett; Udayan Ray
Journal:  Arch Rheumatol       Date:  2016-07-27       Impact factor: 1.472

Review 2.  Health disparities in systemic lupus erythematosus-a narrative review.

Authors:  Bilal Hasan; Alice Fike; Sarfaraz Hasni
Journal:  Clin Rheumatol       Date:  2022-07-31       Impact factor: 3.650

Review 3.  Cardiovascular involvement in autoimmune diseases.

Authors:  Jenny Amaya-Amaya; Laura Montoya-Sánchez; Adriana Rojas-Villarraga
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

4.  Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland.

Authors:  Yves Jackson; Drenusha Vieira de Mello Pula; Axel Finckh; Carlo Chizzolini; François Chappuis
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-05       Impact factor: 2.743

Review 5.  Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner.

Authors:  Irini Gergianaki; George Bertsias
Journal:  Front Med (Lausanne)       Date:  2018-05-29

6.  First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Authors:  Bernardo A Pons-Estel; Eloisa Bonfa; Enrique R Soriano; Mario H Cardiel; Ariel Izcovich; Federico Popoff; Juan M Criniti; Gloria Vásquez; Loreto Massardo; Margarita Duarte; Leonor A Barile-Fabris; Mercedes A García; Mary-Carmen Amigo; Graciela Espada; Luis J Catoggio; Emilia Inoue Sato; Roger A Levy; Eduardo M Acevedo Vásquez; Rosa Chacón-Díaz; Claudio M Galarza-Maldonado; Antonio J Iglesias Gamarra; José Fernando Molina; Oscar Neira; Clóvis A Silva; Andrea Vargas Peña; José A Gómez-Puerta; Marina Scolnik; Guillermo J Pons-Estel; Michelle R Ugolini-Lopes; Verónica Savio; Cristina Drenkard; Alejandro J Alvarellos; Manuel F Ugarte-Gil; Alejandra Babini; André Cavalcanti; Fernanda Athayde Cardoso Linhares; Maria Jezabel Haye Salinas; Yurilis J Fuentes-Silva; Ana Carolina Montandon de Oliveira E Silva; Ruth M Eraso Garnica; Sebastián Herrera Uribe; Diana Gómez-Martín; Ricardo Robaina Sevrini; Rosana M Quintana; Sergio Gordon; Hilda Fragoso-Loyo; Violeta Rosario; Verónica Saurit; Simone Appenzeller; Edgard Torres Dos Reis Neto; Jorge Cieza; Luis A González Naranjo; Yelitza C González Bello; María Victoria Collado; Judith Sarano; Soledad Retamozo; María E Sattler; Rocio V Gamboa-Cárdenas; Ernesto Cairoli; Silvana M Conti; Luis M Amezcua-Guerra; Luis H Silveira; Eduardo F Borba; Mariana A Pera; Paula B Alba Moreyra; Valeria Arturi; Guillermo A Berbotto; Cristian Gerling; Carla A Gobbi; Viviana L Gervasoni; Hugo R Scherbarth; João C Tavares Brenol; Fernando Cavalcanti; Lilian T Lavras Costallat; Nilzio A Da Silva; Odirlei A Monticielo; Luciana Parente Costa Seguro; Ricardo M Xavier; Carolina Llanos; Rubén A Montúfar Guardado; Ignacio Garcia de la Torre; Carlos Pineda; Margarita Portela Hernández; Alvaro Danza; Marlene Guibert-Toledano; Gil Llerena Reyes; Maria Isabel Acosta Colman; Alicia M Aquino; Claudia S Mora-Trujillo; Roberto Muñoz-Louis; Ignacio García Valladares; María Celeste Orozco; Paula I Burgos; Graciela V Betancur; Graciela S Alarcón
Journal:  Ann Rheum Dis       Date:  2018-07-25       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.